SODIUM PHENYLACETATE AND SODIUM BENZOATE

Generic: SODIUM PHENYLACETATE AND SODIUM BENZOATE

MAIA PHARMACEUTICALSManufacturer
INTRAVENOUSRoute
SODIUM PHENYLACETATEActive Substance
2021-06-10Original Approval

SODIUM PHENYLACETATE AND SODIUM BENZOATE is FDA application NDA215025, sponsored by MAIA PHARMS INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DRUG INEFFECTIVE
5 reports
2
HYPERGLYCAEMIA
2 reports
3
AMMONIA DECREASED
1 reports
4
ANION GAP INCREASED
1 reports
5
BLOOD LACTIC ACID INCREASED
1 reports
6
BRAIN OEDEMA
1 reports
7
CEREBRAL INFARCTION
1 reports
8
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION
1 reports
9
MATERNAL EXPOSURE DURING PREGNANCY
1 reports
10
MYCOPLASMA TEST POSITIVE
1 reports